Skip to main content

For US Healthcare Professionals Only

Quick Links

Prescribing Information
Adverse Event Reporting
- Report an Adverse Event or Product Complaint
- Email
- 1-844-599-CARE (2273)
Connect with an MSL
Connect With Us

Main navigation

Home
Our Science
Disease Education
Congress Materials
Medical Information
Slide Library
HCP Resources
Prescribing Information
Connect With an MSL
Connect With Us
BIMZELX® (bimekizumab-bkzx)
CIMZIA® (certolizumab pegol)
RYSTIGGO® (rozanolixizumab-noli)
ZILBRYSQ® (zilucoplan)

Home
Congress Materials
American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM), 2024

< Back to search results

Social determinants of health are associated with delayed diagnosis in myasthenia gravis

View PDF

Footer Left

UCB-Cares.com
UCB-USA.com
UCB.com

BIMZELX®, CIMZIA®, RYSTIGGO®, ZILBRYSQ®, UCBCares®, and UCBCOMPASS® are registered trademarks of the UCB Group of Companies. All other trademarks are the property of their respective holders.

©2024 UCB, Inc., Smyrna, GA 30080. All rights reserved. All data collected on this site is governed by UCB’s Privacy Policy, Cookies Policy, as well as the site Terms and Conditions. This site is intended for US Healthcare Professionals only.

US-S-BK-AS-2200006 November 2024

Sticky notice

Announcements

RHEUMATOLOGY

BIMZELX^® (bimekizumab-bkzx) is now FDA approved for the treatment of adults with active PsA, nr-axSpA, and AS. See the phase 3 clinical trial data in Publications.

DERMATOLOGY

BIMZELX^® (bimekizumab-bkzx) is now FDA approved for the treatment of adults with moderate-to-severe hidradenitis suppurativa (HS). See the phase 3 clinical trial data in Publications.

UCB continues to proactively monitor the COVID-19 situation. To learn more about UCB's preparedness, click here.

RHEUMATOLOGY

The Women's Health Fellowship Program application is now closed. Learn More

You are now leaving UCBCOMPASS^®

UCBCOMPASS^® offers links to third-party websites provided solely for your convenience that may assist you in locating other useful information. UCB is not responsible for content or privacy policies on linked third-party websites that are not under the control of UCB. Do you wish to continue?

Cancel Yes, Continue

This site is intended for Healthcare Professionals licensed in the United States.

UCBCOMPASS^® provides accurate, unbiased, and non-promotional scientific education and medical information on UCB products and disease areas of focus. This content is for informational purposes only and is not intended as medical advice. It may include information about products or uses that have not been approved by the U.S. Food and Drug Administration.

Notice about cookies
This website uses a limited number of cookies to improve your browsing experience. For further information (including how to withdraw consent), please refer to our Cookie Policy.

By clicking “Confirm” I certify that I am a U.S. Healthcare Professional and have read and consent to this site’s use of cookies.

I am a patient or caregiver I am a non-U.S. Healthcare Professional

Footer Right

contactAll
Home
Contact Us
Site Map

TOP